Patent · US Active

Stable Tregs and related materials and methods

US9018006B2 · kind B2 · utility

6Cited by
30References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 25, 2011
Grant dateApr 28, 2015
Priority date
Expiry dateOct 29, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2501/727
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides materials and methods related to culturing stable Treg cells or in vivo expansion of stable Treg cells, the cells made by the methods, treatments for various inflammatory/autoimmune pathologies and transplant/graft rejection, and related materials. Ex vivo induction and expansion of the stable Tregs is described, including use of inducing compositions, such as certain mAbs and other compounds, along with expansion medium comprising IL-2. In vivo expansion of stable Treg cells and treatments for various inflammatory/autoimmune pathologies and transplant/graft rejection are described, including the use of mAbs and their variants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.